European Heart Journal Advance Access originally published online on August 15, 2005
European Heart Journal 2005 26(22):2463-2471; doi:10.1093/eurheartj/ehi426
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recommendations for the management of patients after heart valve surgery
Received 23 May 2005; accepted 23 June 2005; online publish-ahead-of-print 15 August 2005.
* Corresponding author. Department of Cardiothoracic Surgery, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, UK. Tel: +44 29 2074 3284; fax: +44 1446 781 316. E-mail address: egbutchart{at}aol.com
Abstract
Approximately 50 000 valve replacement operations take place in Europe annually and almost as many valve repair procedures. Previous European guidelines on management of patients after valve surgery were last published in 1995 and were limited to recommendations about antithrombotic prophylaxis.1 American guidelines covering the broader topic of the investigation and treatment of patients with valve disease were published in 1998 but devoted relatively little space to post-surgical management.2 This document represents the consensus view of a committee drawn from three European Society of Cardiology (ESC) Working Groups (WG): the WG on Valvular Heart Disease, the WG on Thrombosis, and the WG on Rehabilitation and Exercise Physiology.
In almost all areas of patient management after valve surgery, randomized trials and meta-analyses do not exist. Such randomized trials as do exist are very few in number, are narrowly focused with small numbers, have limited general applicability, and do not lend themselves to meta-analysis because of widely divergent methodologies and different patient characteristics. Recommendations are therefore almost entirely based on non-randomized studies and relevant basic science.
Key Words: Heart valve • Surgery • Follow-up • Rehabilitation • Anticoagulation • Thrombosis • Thromboembolism • Endocarditis • Haemolysis • Pregnancy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Akhtar, A. R Abid, H. Zafar, M. A Cheema, and J. S Khan Anticoagulation in Pregnancy with Mechanical Heart Valves: 10-Year Experience Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 497 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Herijgers and P. Verhamme Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Eur. Heart J., October 2, 2007; 28(20): 2424 - 2426. [Full Text] [PDF]
|
|
|
|
|
|
K. Mischke Management of pregnant women with artificial heart valves: inconsistency in ESC publications Eur. Heart J., October 1, 2007; 28(19): 2419 - 2419. [Full Text] [PDF]
|
|
|
|
|
|
M. Brueck, W. Kramer, P. Vogt, N. Steinert, P. Roth, G. Gorlach, M. Schonburg, and M. C. Heidt Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 108 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lopes, P. Calvinho, F. de Oliveira, and M. Antunes Allograft aortic root replacement in complex prosthetic endocarditis Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 126 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bayliss, P. Faber, J. Dunning, and A. Ronald What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve? Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 390 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, C. Baigent, J. Jespersen, S. D. Kristensen, G. Montalescot, A. Siegbahn, et al. Anticoagulants in heart disease: current status and perspectives Eur. Heart J., April 10, 2007; (2007) ehl492v1. [Full Text] [PDF]
|
|
|
|
|
|
J. Dunning Laws, Guidelines and professional choice Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 571 - 572. [Full Text] [PDF]
|
|
|
|
|
|
J. Nowell, E. Wilton, H. Markus, and M. Jahangiri Antithrombotic therapy following bioprosthetic aortic valve replacement Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 578 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.R. E. Jamieson, S. D. Moffatt-Bruce, P. Skarsgard, M. A. Hadi, J. Ye, G. J. Fradet, J. G. Abel, M. T. Janusz, A. Cheung, and E. Germann Early Antithrombotic Therapy for Aortic Valve Bioprostheses: Is There an Indication for Routine Use? Ann. Thorac. Surg., February 1, 2007; 83(2): 549 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374. [Full Text] [PDF]
|
|
|
|
|
|
S. Asopa, A. Patel, and J. Dunning Is short-term anticoagulation necessary after mitral valve repair? Interactive CardioVascular and Thoracic Surgery, December 1, 2006; 5(6): 761 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pavy, M. C. Iliou, P. Meurin, J.-Y. Tabet, S. Corone, and for the Functional Evaluation and Cardiac Rehabili Safety of Exercise Training for Cardiac Patients: Results of the French Registry of Complications During Cardiac Rehabilitation Arch Intern Med, November 27, 2006; 166(21): 2329 - 2334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. El-Husseiny, K. Salhiyyah, S. G. Raja, and J. Dunning Should warfarin be routinely prescribed for the first three months after a bioprosthetic valve replacement? Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 616 - 623. [Abstract] [Full Text] [PDF]
|
|